Delivery Order SPE2DB22D1106-SPE2DB23FEHD3
Award Date 5/10/23
Potential Completion Date 5/11/23
Potential Value $19K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGES to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $20,147.10, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the larger Amerisourcebergen Corporation. This contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award is for the delivery of STELARA 90 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, through its Corporate Office Division. This is a firm fixed-price delivery order contract with a ceiling value of $47,003.95 and an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) has awarded a delivery order worth $14,751.21 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide STELARA 90 MG/ML syringes. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military...
- The federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $37,312.83, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is May 16, 2023. The contract is not designated with a specific set-aside....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,364.40, is for the delivery of Stelara 90 mg/ml syringes. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the...
- This federal contract award is for the delivery of Stelara 90 mg/ml syringes to the Defense Logistics Agency (DLA). The contract has a ceiling value of $11,204.07 and an ultimate completion date of April 24, 2023. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that serves as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The contract is a delivery order, with a...
- This federal contract award is for the delivery of Stelara 90 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a total ceiling value of $24,814.83. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 25, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite...
- This federal contract award, valued at $7,400.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract provides for the delivery of Stelara 90 mg/ml syringes, a specialty pharmaceutical product. The award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a delivery order contract valued at $30,858.83 for the supply of STELARA 90 MG/ML syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
- This federal contract award is for the delivery of STELARA 45 MG/0.5 ML syringes to the Defense Logistics Agency (DLA). The contract, valued at $9,549.76, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also does business as Amerisourcebergen. The contract is a Delivery Order (DO) under an Indefinite Delivery Contract (IDC) that Cencora, Inc....